Research output per year
Research output per year
Fingerprint
Dive into the research topics where Varda Shoshan-Barmatz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology (Translational Neurodegeneration, (2022), 11, 1, (58), 10.1186/s40035-022-00329-7)
Verma, A., Shteinfer-Kuzmine, A., Kamenetsky, N., Pittala, S., Paul, A., Nahon Crystal, E., Ouro, A., Chalifa-Caspi, V., Pandey, S. K., Monsonego, A., Vardi, N., Knafo, S. & Shoshan-Barmatz, V., 1 Dec 2023, In: Translational Neurodegeneration. 12, 1, 2.Research output: Contribution to journal › Comment/debate
Open Access -
Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets
Pessoa, J., Martins, M., Casimiro, S., Pérez-Plasencia, C. & Shoshan-Barmatz, V., 22 Jun 2022, In: Frontiers in Oncology. 12, 949139.Research output: Contribution to journal › Editorial
Open Access -
Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
Pandey, S. K., Shteinfer-Kuzmine, A., Chalifa-Caspi, V. & Shoshan-Barmatz, V., 14 Sep 2022, In: Frontiers in Oncology. 12, 992260.Research output: Contribution to journal › Article › peer-review
Open Access -
Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks
Pandey, S. K., Machlof-Cohen, R., Santhanam, M., Shteinfer-Kuzmine, A. & Shoshan-Barmatz, V., 1 Jul 2022, In: Biomolecules. 12, 7, 895.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS
Shteinfer-Kuzmine, A., Argueti-Ostrovsky, S., Leyton-Jaimes, M. F., Anand, U., Abu-Hamad, S., Zalk, R., Shoshan-Barmatz, V. & Israelson, A., 1 Sep 2022, In: International Journal of Molecular Sciences. 23, 17, 9946.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Verma, A., Shteinfer-Kuzmine, A., Kamenetsky, N., Pittala, S., Paul, A., Nahon Crystal, E., Ouro, A., Chalifa-Caspi, V., Pandey, S. K., Monsengo, A., Vardi, N., Knafo, S. & Shoshan-Barmatz, V., 1 Dec 2022, In: Translational Neurodegeneration. 11, 1, 58.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The Multicellular Effects of VDAC1 N-Terminal-Derived Peptide
Anand, U., Shteinfer-Kuzmine, A., Sela, G., Santhanam, M., Gottschalk, B., Boujemaa-Paterski, R., Medalia, O., Graier, W. F. & Shoshan-Barmatz, V., 1 Oct 2022, In: Biomolecules. 12, 10, 1387.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
Verma, A., Pittala, S., Alhozeel, B., Shteinfer-Kuzmine, A., Ohana, E., Gupta, R., Chung, J. H. & Shoshan-Barmatz, V., 2 Feb 2022, In: Molecular Therapy. 30, 2, p. 726-744 19 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Shoshan-Barmatz, V., Anand, U., Nahon-Crystal, E., Di Carlo, M. & Shteinfer-Kuzmine, A., 4 Oct 2021, In: Frontiers in Physiology. 12, 730048.Research output: Contribution to journal › Review article › peer-review
Open Access16 Scopus citations -
Novel piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction
Shoshan-Barmatz, V. & Lev Gruzman, A., 25 Feb 2021, IPC No. C07D 403/ 04 A I, Patent No. AU2021200421, Priority date 22 Jan 2021, Priority No. AU20210200421Research output: Patent
Press / Media
-
New Findings from Ben-Gurion University of the Negev in the Area of Cancer Reported (Smac/diablo Controls Proliferation of Cancer Cells By Regulating Phosphatidylethanolamine Synthesis)
Varda Shoshan-Barmatz, Ran Zalk & Swaroop Kumar Pandey
19/12/22
1 item of Media coverage
Press/Media
-
Making the desert bloom with biotechnology
Varda Shoshan-Barmatz, Ran Zalk, Tomer Hertz & Ohad Birk
7/06/19
1 item of Media coverage
Press/Media